Your shopping cart is currently empty

Pan-RAS-IN-2 (compound 6A) is an orally active molecular glue that targets RAS by inducing ternary complex formation with cyclophilin A (CYPA) and RAS in the ON state, leading to potent inhibition of downstream RAF binding and pERK signaling with an IC50 of 0.3 nM in AsPC-1 cells, Pan-RAS-IN-2 demonstrates strong antiproliferative effects in RAS-mutant cancer cell lines, supporting research into targeted therapies for colorectal and pancreatic cancers.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $158 | - | In Stock | |
| 5 mg | $396 | - | In Stock | |
| 10 mg | $635 | - | In Stock | |
| 25 mg | $1,280 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $585 | - | In Stock |
| Description | Pan-RAS-IN-2 (compound 6A) is an orally active molecular glue that targets RAS by inducing ternary complex formation with cyclophilin A (CYPA) and RAS in the ON state, leading to potent inhibition of downstream RAF binding and pERK signaling with an IC50 of 0.3 nM in AsPC-1 cells, Pan-RAS-IN-2 demonstrates strong antiproliferative effects in RAS-mutant cancer cell lines, supporting research into targeted therapies for colorectal and pancreatic cancers. |
| Targets&IC50 | pERK:0.3 nM |
| In vitro | In AsPC-1 pancreatic cancer cells, Pan-RAS-IN-2 potently inhibited pERK levels with an IC50 of 0.3 nM. The compound demonstrated significant antiproliferative activity across a broad spectrum of RAS-mutant cancer cell lines, including those harboring KRAS G12D, G12V, and G12C mutations [1]. |
| In vivo | Pan-RAS-IN-2 exhibited robust antitumor efficacy in mouse xenograft models of RAS-driven cancers, such as colorectal and pancreatic cancer. Oral administration of Pan-RAS-IN-2 resulted in the significant inhibition of tumor growth [1]. |
| Molecular Weight | 837.08 |
| Formula | C46H60N8O5S |
| Cas No. | 3034673-92-9 |
| Smiles | O=C1OCC(C)(C)CC=2C3=CC(=CC=C3N(C2C=4C=C(C=NC4C(OC)C)N5CCN(C)CC5)CC)C=6N=C(SC6)CC(NC(=O)C7C(C)C7C)C(=O)N8NC1C9CC8C9 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (95.57 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.